[Federal Register Volume 69, Number 153 (Tuesday, August 10, 2004)]
[Notices]
[Page 48524]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-18169]



[[Page 48524]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By notice dated February 4, 2004 and published in the Federal 
Register on February 18, 2004, (69 FR 7656), Lipomed, Inc., One 
Broadway, Cambridge, Massachusetts 02142, made application to the Drug 
Enforcement Administration (DEA) to be registered as an importer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methaqualone (2565)........................  I
Gamma-Hydroxybutyric Acid (2010)...........  I
Lysergic acid diethylamide (7315)..........  I
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
Mescaline (7381)...........................  I
3, 4, 5-Trimethoxyamphetamine (7390).......  I
4-Bromo-2-5-dimethoxyamphetamine (7391)....  I
4-Methyl-2, 5-dimethoxyamphetamine (7395)..  I
2, 5-Dimethoxyamphetamine (7396)...........  I
2, 5-Dimethoxy-4-ethylamphetamine (7399)...  I
3, 4-Methylenedioxyamphetamine (7400)......  I
3, 4-Methylenedioxy-N-ethylamophetamine      I
 (7404).
3, 4-Methylenedioxymethamphetamine (7405)..  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
Acetyldihydrocodeine (9051)................  I
Dihydromorphine (9145).....................  I
Heroin (9200)..............................  I
Tilidine (9750)............................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Amobarbital (2125).........................  II
Secobarbital (2315)........................  II
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Benzoylecgonine (9180).....................  II
Hydrocodone (9193).........................  II
Levorphanol (9220).........................  II
Methadone (9250)...........................  II
Dextropropoxyphene (9273)..................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Oxymorphone (9652).........................  II
Alfentanil (9737)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to import small reference standard quantities of 
finished commercial product from its sister company in Switzerland for 
sale to its customers for drug testing and pharmaceutical research and 
development.
    No comments or objections have been received. DEA has considered 
the factors contained in Title 21, United States Code, Section 823(a) 
and determined that the registration of Lipomed, Inc. to import the 
listed controlled substance is consistent with the public interest and 
with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971, at this time. DEA 
has investigated Lipomed, Inc. to ensure that the company's 
registration is consistent with the public interest. This investigation 
included inspection and testing of the compnay's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to Section 1008(a) of the Controlled Substances Import and 
Export Act and in accordance with Title 21, Code of Federal 
Regulations, Section 1301.34, the above firm is granted registration as 
an importer of the basic class of controlled substance listed above.

    Dated: June 28, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-18169 Filed 8-9-04; 8:45 am]
BILLING CODE 4410-09-M